HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigens

OncoImmunology

Volumn 2, Issue 3, 2013, Pages

  Xu, Qing Wen ^a,c   Zhang, Yu ^a   Wang, Xiao Song ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Autoantibody signatures; Gene expression profiling; Immunodiagnosis; Tumor specific antigen

Indexed keywords

AUTOANTIBODY; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IQGAP3 ANTIGEN; MELANOMA ANTIGEN 3; PRAME ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VESTIGIAL LIKE 1 ANTIGEN;

ALGORITHM; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION PROFILING; GENE ISOLATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENOME ANALYSIS; HETEROGENOUS EXPRESSION PROFILE ANALYSIS; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN A G BASED REVERSE SEROLOGICAL EVALUATION;

EID: 84886944022     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23249     Document Type: Article

References (10)

1. Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Immunotherapy of cancer in 2012. CA Cancer J Clin 2012; 62:309-35; PMID:22576456; http://dx.doi.org/10.3322/caac.20132.
2. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al.; IMPACT Study Investigators. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 2010; 363:411-22; PMID:20818862; http://dx.doi.org/10.1056/NEJMoa1001294.
3. Charoentong P, Angelova M, Efremova M, Gallasch R, Hackl H, Galon J, et al. Bioinformatics for cancer immunology and immunotherapy. Cancer Immunol Immunother 2012; 61:1885-903; PMID:22986455; http://dx.doi.org/10.1007/s00262-012-1354-x.
4. Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 2006; 12:4851-8; PMID:16914571; http://dx.doi.org/10.1158/1078-0432.CCR-06-0134.
5. Xu QW, Zhao W, Wang Y, Sartor MA, Han DM, Deng J, et al. An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer. Cancer Res 2012; 72:6351-61; PMID:23135912; http://dx.doi.org/10.1158/0008-5472.CAN-12-1656.
6. Wang X, Zhao H, Xu Q, Jin W, Liu C, Zhang H, et al. HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma. Nucleic Acids Res 2006; 34(Database issue):D607-12; PMID:16381942; http://dx.doi.org/10.1093/nar/gkj082.
7. Epping MT, Wang L, Edel MJ, Carlée L, Hernandez M, Bernards R. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 2005; 122:835-47; PMID:16179254; http://dx.doi.org/10.1016/j.cell.2005.07.003.
8. Doyle JM, Gao J, Wang J, Yang M, Potts PR. MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 2010; 39:963-74; PMID:20864041; http://dx.doi.org/10.1016/j.molcel.2010.08.029.
9. Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S, Tsukita S. IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade.Nat Cell Biol 2008; 10:971-8; PMID:18604197; http://dx.doi.org/10.1038/ncb1757.
10. Pobbati AV, Chan SW, Lee I, Song H, Hong W. Structural and functional similarity between the Vgll1- TEAD and the YAP-TEAD complexes.Structure 2012; 20:1135-40; PMID:22632831; http://dx.doi.org/10.1016/j.str.2012.04.004.